Infinium Global Research T-Cell Immunotherapy Market | Page 3

T-Cell Immunotherapy Market: Trends and Forecast -2024
anticipated to boost the growth of T cell immunotherapy market. However, the
neurological problems associated with the T cell immunotherapy is expected to be
the restraining factor in the T cell immunotherapy market. Moreover, various
health organizations and government agencies are taking initiative to find effective
therapy to treat cancer. The rapidly increasing research and development activities
and technological advancement in the cancer treatment are projected to create
several opportunities for the T cell immunotherapy market in upcoming years.
Furthermore, The Food and Drug Administration (FDA) has approved CAR T-cell
therapy, axicabtagene ciloleucel (Yescarta), for the treatment of diffuse large B-cell
lymphoma (DLBCL) and CAR T-cell therapy tisagenlecleucel (Kymriah) to treat
cancer in the Childers and adults.
Geographically, North America held the maximum market share in the T cell
Immunotherapy market owing to the rising occurrence of cancer. The developed
healthcare infrastructure of North America contributes in the growth of T cell
Immunotherapy market. In addition, Asia pacific is the fastest growing region in the
T cell Immunotherapy. The developing healthcare infrastructure, growing geriatric
population and rising occurrence of cancer are the primary factors driving the
growth of T cell Immunotherapy market in the Asia Pacific region
Segment Covered
The report on global t-cell immunotherapy market covers segments such as,
mechanism of action, type of therapy and product class. On the basis of mechanism
of action the global t-cell immunotherapy market is categorized into active
immunotherapy and passive immunotherapy. On the basis of type of therapy the
global t-cell immunotherapy market is categorized into car-T, TCR and TIL. On the
basis of product class the global t-cell immunotherapy market is categorized into
monoclonal antibodies, oncolytic virus therapy, bispecific antibodies and cytokines.
Geographic Coverage
The countries covered in the North America region include the U.S., Canada, and
Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and
among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are
included in the European region. The U.S. drives the growth in the North America
region as it is the largest market in the region. The Asia-pacific region offers a
substantial potential for the market growth owing to rapid growth in markets such
3
© Infinium Global Research